sensit
molecular
techniqu
need
rapid
detect
oseltamivirresist
mutant
influenza
viru
strain
monitor
transmiss
guid
antivir
treatment
develop
realtim
revers
transcript
pcr
singl
nucleotid
polymorph
probe
differenti
mutant
strain
mix
viru
popul
human
specimen
n
outbreak
human
infect
novel
reassort
avianorigin
influenza
viru
occur
sever
provinc
china
march
outbreak
caus
laboratoryconfirm
case
death
octob
wwwwhointcsr
unusu
high
proport
sever
case
high
casefat
rate
observ
patient
infect
viru
report
emerg
influenza
viru
mutat
neuraminidas
na
gene
associ
sever
clinic
outcom
infect
person
studi
shown
na
mutat
caus
high
level
resist
oseltamivir
influenza
viru
thu
sensit
molecular
techniqu
need
rapid
detect
influenza
viru
mutat
monitor
circul
transmiss
guid
antivir
treatment
studi
develop
singlenucleotid
polymorph
snp
realtim
revers
transcript
pcr
rtpcr
differenti
na
mutant
viru
wildtyp
viru
clinic
sampl
na
assay
reaction
pair
primer
one
reaction
contain
famlabel
snp
probe
specif
mutant
strain
second
reaction
contain
viclabel
probe
specif
wildtyp
strain
onlin
technic
appendix
wwwnccdcgov
assess
sensit
assay
construct
plasmid
contain
wildtyp
viru
mutant
viru
respect
fragment
na
gene
insert
plasmid
amplifi
nasopharyng
swab
specimen
patient
infect
influenza
viru
confirm
use
sanger
sequenc
onlin
technic
appendix
plasmid
serial
dilut
copi
steril
water
use
test
assay
linear
rang
sensit
copi
lower
limit
detect
copiesreact
reaction
detect
wildtyp
mutant
viru
figur
howev
sensit
duplex
reaction
contain
probe
lower
separ
reaction
respiratori
sampl
test
infect
influenza
influenza
viru
influenza
viru
parainfluenza
viru
human
rhinoviru
human
coronaviru
influenza
b
viru
respiratori
syncyti
viru
addit
respiratori
sampl
viru
neg
crossamplif
observ
sampl
test
thu
assay
highli
specif
detect
mutant
na
gene
influenza
viru
test
perform
assay
mutant
wildtyp
virus
present
sampl
seri
mixtur
contain
plasmid
plasmid
copi
number
copiesreact
prepar
follow
ratio
mutant
viru
wildtyp
viru
k
r
mixtur
ratio
use
assayspecif
normal
valu
determin
percentag
mutant
mix
popul
describ
liu
et
al
assay
detect
mutant
mixtur
proport
copiesreact
correct
estim
proport
rang
onlin
technic
appendix
valid
assay
clinic
sampl
test
pair
nasopharyng
swab
specimen
sputum
specimen
obtain
patient
infect
influenza
viru
variou
diseas
outcom
tabl
time
sampl
mean
day
rang
day
end
treatment
na
inhibitor
oseltamivir
peramivir
afterward
eleven
sampl
posit
influenza
viru
quantit
realtim
rtpcr
describ
previou
studi
seven
sampl
posit
result
assay
sampl
posit
assay
sampl
posit
assay
four
sampl
neg
assay
sampl
confirm
posit
sanger
sequenc
na
gene
sampl
contain
mutant
obtain
patient
patient
die
patient
patient
recov
patient
previou
studi
sequenc
na
gene
success
first
throat
swab
specimen
patient
low
viral
load
howev
studi
mutant
found
sputum
specimen
patient
day
respect
initi
antivir
treatment
find
suggest
influenza
viru
mutat
pressur
antivir
treatment
led
failur
viru
clear
lower
respiratori
tract
patient
infect
drugresist
mutant
viru
recov
diseas
suggest
host
immun
respons
might
play
major
role
control
mutant
viru
higher
viral
load
sputum
sampl
indic
might
factor
includ
hemagglutinin
ha
bind
prefer
favor
greater
replic
lower
respiratori
tract
similar
phenomenon
observ
patient
infect
ha
mutant
influenza
viru
viru
show
preferenti
replic
lower
respiratori
tract
infect
correl
sever
outcom
death
develop
snp
realtim
rtpcr
detect
drugresist
na
mutant
influenza
viru
sensit
assay
lower
realtim
rtpcr
ie
sampl
posit
influenza
viru
detect
rtpcr
howev
screen
tool
assay
sensit
specif
fast
inexpens
assay
detect
threshold
mutant
strain
mix
viral
popul
sensit
sanger
sequenc
detect
threshold
minor
compon
mix
viral
popul
assay
help
clinician
monitor
emerg
drugresist
viru
strain
treatment
patient
na
inhibitor
prevent
persist
viral
replic
sever
inflammatori
reaction
sign
twitter
find
latest
inform
emerg
infecti
diseas
eid
journal
cdceidjourn
